HFS
EBS icon

HBC Financial Services’s Emergent Biosolutions EBS Stock Holding History

HBC Financial Services’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$9K Sell
1,000
-1,000
-50% -$9.18K 0.01% 120
2024
Q3 		$19K Buy
+2,000
New +$18.2K 0.01% 101

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
OHA
Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

HBC Financial Services's EBS Position: Q4 2024 in Review

HBC Financial Services reduced its Emergent Biosolutions (EBS) stake by 50% in Q4 2024, selling an estimated $9.18K and leaving 1,000 shares worth $9K. The position accounts for 0.01% of the portfolio, ranked #120.

HBC Financial Services first reported a position in EBS in Q3 2024 and has held it in 2 quarters since. The position peaked at $19K in Q3 2024. 156 funds tracked by Wall St. Rank hold EBS as of Q4 2024.

  • HBC Financial Services held 1,000 shares of Emergent Biosolutions worth $9K as of Q4 2024.
  • HBC Financial Services sold 1,000 Emergent Biosolutions shares in Q4 2024, an estimated $9.18K.
  • Emergent Biosolutions made up 0.01% of HBC Financial Services's portfolio in Q4 2024, its #120 holding.
  • HBC Financial Services first reported a position in Emergent Biosolutions in Q3 2024 and has held it in 2 quarters since.
  • HBC Financial Services's Emergent Biosolutions position peaked at $19K in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2024.

Based on HBC Financial Services's 13F filing for Q4 2024, filed 16 Jan 2025.